Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $6,940 | $7,312 | – | $7,593 |
| - Cash | $0 | $578 | – | $818 |
| + Debt | $0 | $47 | – | $51 |
| Enterprise Value | $6,940 | $6,781 | – | $6,825 |
| Revenue | $1,349 | – | $1,274 | $1,300 |
| % Growth | – | – | -2% | – |
| Gross Profit | $1,189 | – | $1,133 | $1,147 |
| % Margin | 88.1% | – | 89% | 88.3% |
| EBITDA | $379 | – | $400 | $346 |
| % Margin | 28.1% | – | 31.4% | 26.6% |
| Net Income | $255 | – | $262 | $201 |
| % Margin | 18.9% | – | 20.6% | 15.4% |
| EPS Diluted | 2.62 | – | 2.69 | 1.96 |
| % Growth | – | – | 37.2% | – |
| Operating Cash Flow | $472 | – | $327 | $367 |
| Capital Expenditures | -$42 | – | -$30 | -$30 |
| Free Cash Flow | $430 | – | $297 | $337 |